| Literature DB >> 22883912 |
Sheila Raghavan1, Dina Abbas, Beverly Winikoff.
Abstract
Misoprostol is an effective and safe uterotonic for the prevention and treatment of postpartum hemorrhage (PPH). A 600-μg oral dose of misoprostol has been shown to prevent PPH in community-based randomized controlled trials. An 800-μg sublingual dose of misoprostol appears to be a good first-line treatment for controlling PPH. Adverse effects after use of misoprostol for PPH prevention or treatment may include shivering and fever. These effects are transient, resolve on their own, and are not life threatening. Misoprostol can play an important role in settings with limited access to oxytocin, and where there is no other option for PPH care.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22883912 DOI： 10.1016/j.ijgo.2012.03.013
Source DB: PubMed Journal: Int J Gynaecol Obstet ISSN： 0020-7292 Impact factor: 3.561